Partner Headlines - FOLD

  1. The Biotech Stock With The Best One-Week Performance

    Benzinga
  2. Stocks Hitting 52-Week Highs

    Benzinga
  3. Morning Market Movers

    Benzinga
  4. Benzinga's Top #PreMarket Gainers

    Benzinga
  5. Morning Market Movers

    Benzinga
  6. Amicus Extending Rally On Upgrades

    Benzinga
  7. Benzinga's Top Upgrades

    Benzinga
  8. Benzinga's Top #PreMarket Gainers

    Benzinga
  9. Morning Market Movers

    Benzinga
  10. Benzinga's Top #PreMarket Gainers

    Benzinga
  11. Earnings Scheduled For March 3, 2014

    Benzinga
  12. UPDATE: J.P. Morgan Downgrades Amicus Therapeutics On Cautious ...

    Benzinga
  13. Gilead Sciences Leads In Rising Short Interest Among Biotechs ...

    Benzinga
  14. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics ...

    Benzinga
  15. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, ...

    Benzinga
  16. Amicus, Biogen Announce Deal for Discovery, Development, Commercialization ...

    Benzinga
  17. Amicus Therapeutics Says Added 6-Month Results from Phase 3 Fabry ...

    Benzinga
  18. Amicus Therapeutics Advances Chaperone-ERT Combo Platform in ...

    Benzinga
  19. Amicus Announces Positive Phase 2 Results for Chaperone-Enzyme ...

    Benzinga
  20. Stocks Hitting 52-Week Lows

    Benzinga
  21. UPDATE: Wedbush Downgrades Amicus Therapeutics to Underperform ...

    Benzinga
  22. Option Traders Call a Bottom for Amicus Therapeutics

    SchaeffersResearch
  23. GlaxoSmithKline

    IBD
  24. Amicus, Glaxo Release Top-Line Six-Month Primary Treatment Period ...

    Benzinga
  25. Amicus Therapeutics Announces Additional Preliminary Results ...

    Benzinga
  26. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-Q)

    GuruFocus
  27. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-Q)

    GuruFocus
  28. UPDATE: Canaccord Reiterates Buy Rating, Raises PT on Amicus ...

    Benzinga
  29. Amylin Pharmaceuticals, Best Buy Among Stocks Up on High Volume ...

    FoxBusiness
  30. Benzinga's Top Upgrades with Color for May 8, 2012

    Benzinga
  31. UPDATE: J.P. Morgan Upgrades Amicus Therapeutics

    Benzinga
  32. From Earlier: Amicus Therapeutics Prices Underwritten Offering ...

    Benzinga
  33. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-K)

    GuruFocus
  34. Amicus Therapeutics Presents Preclinical Studies of Chaperone ...

    Benzinga
  35. Amicus Therapeutics Announces Positive Preliminary Results From ...

    Benzinga
Trading Center